MYDA Advisors’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
MYDA Advisors's KURA Position: Q3 2026 in Review
MYDA Advisors opened a new position in Kura Oncology (KURA) in Q3 2026: 30,000 shares worth $321K. The stake represents 0.04% of the portfolio and ranks #175 among its holdings. This is a return to the name: MYDA Advisors previously reported a position in KURA as recently as Q2 2024.
MYDA Advisors first reported a position in KURA in Q1 2022 and has held it in 11 quarters since. The position peaked at $846K in Q2 2023. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.
- MYDA Advisors held 30,000 shares of Kura Oncology worth $321K as of Q3 2026.
- Kura Oncology was a new MYDA Advisors position in Q3 2026.
- Kura Oncology made up 0.04% of MYDA Advisors's portfolio in Q3 2026, its #175 holding.
- MYDA Advisors first reported a position in Kura Oncology in Q1 2022 and has held it in 11 quarters since.
- MYDA Advisors's Kura Oncology position peaked at $846K in Q2 2023.
- 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.
Based on MYDA Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.